These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 34071605)

  • 21. Role of Galectin-3 in Bone Cell Differentiation, Bone Pathophysiology and Vascular Osteogenesis.
    Iacobini C; Fantauzzi CB; Pugliese G; Menini S
    Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29160796
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of intestinal microbiota and metabolites on gut homeostasis and human diseases.
    Lin L; Zhang J
    BMC Immunol; 2017 Jan; 18(1):2. PubMed ID: 28061847
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relevance of Notch Signaling for Bone Metabolism and Regeneration.
    Ballhause TM; Jiang S; Baranowsky A; Brandt S; Mertens PR; Frosch KH; Yorgan T; Keller J
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33572704
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Crosstalk Between The Immune Receptors and Gut Microbiota.
    Mu C; Yang Y; Zhu W
    Curr Protein Pept Sci; 2015; 16(7):622-31. PubMed ID: 26122782
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Porphyromonas gingivalis Stimulates Bone Resorption by Enhancing RANKL (Receptor Activator of NF-κB Ligand) through Activation of Toll-like Receptor 2 in Osteoblasts.
    Kassem A; Henning P; Lundberg P; Souza PP; Lindholm C; Lerner UH
    J Biol Chem; 2015 Aug; 290(33):20147-58. PubMed ID: 26085099
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mst2 Controls Bone Homeostasis by Regulating Osteoclast and Osteoblast Differentiation.
    Lee J; Youn BU; Kim K; Kim JH; Lee DH; Seong S; Kim I; Han SH; Che X; Choi JY; Park YW; Kook H; Kim KK; Lim DS; Kim N
    J Bone Miner Res; 2015 Sep; 30(9):1597-607. PubMed ID: 25761670
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Periodontal disease and bone pathogenesis: the crosstalk between cytokines and porphyromonas gingivalis.
    Ballini A; Cantore S; Farronato D; Cirulli N; Inchingolo F; Papa F; Malcangi G; Inchingolo AD; Dipalma G; Sardaro N; Lippolis R; Santacroce L; Coscia MF; Pettini F; De Vito D; Scacco S
    J Biol Regul Homeost Agents; 2015; 29(2):273-81. PubMed ID: 26122214
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Liver X receptors orchestrate osteoblast/osteoclast crosstalk and counteract pathologic bone loss.
    Kleyer A; Scholtysek C; Bottesch E; Hillienhof U; Beyer C; Distler JH; Tuckermann JP; Schett G; Krönke G
    J Bone Miner Res; 2012 Dec; 27(12):2442-51. PubMed ID: 22806960
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of osteoclast differentiation and collagen antibody-induced arthritis by CTHRC1.
    Jin YR; Stohn JP; Wang Q; Nagano K; Baron R; Bouxsein ML; Rosen CJ; Adarichev VA; Lindner V
    Bone; 2017 Apr; 97():153-167. PubMed ID: 28115279
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cyclic Dinucleotides Inhibit Osteoclast Differentiation Through STING-Mediated Interferon-β Signaling.
    Kwon Y; Park OJ; Kim J; Cho JH; Yun CH; Han SH
    J Bone Miner Res; 2019 Jul; 34(7):1366-1375. PubMed ID: 30779854
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tissue inhibitor of metalloproteinase 1 suppresses growth and differentiation of osteoblasts and differentiation of osteoclasts by targeting the AKT pathway.
    Xi Y; Huang H; Zhao Z; Ma J; Chen Y
    Exp Cell Res; 2020 Apr; 389(2):111930. PubMed ID: 32113948
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential contribution of osteoclast- and osteoblast-lineage cells to CpG-oligodeoxynucleotide (CpG-ODN) modulation of osteoclastogenesis.
    Amcheslavsky A; Hemmi H; Akira S; Bar-Shavit Z
    J Bone Miner Res; 2005 Sep; 20(9):1692-9. PubMed ID: 16059640
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biglycan deficiency increases osteoclast differentiation and activity due to defective osteoblasts.
    Bi Y; Nielsen KL; Kilts TM; Yoon A; A Karsdal M; Wimer HF; Greenfield EM; Heegaard AM; Young MF
    Bone; 2006 Jun; 38(6):778-86. PubMed ID: 16364709
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thymus-expressed chemokine enhances Porphyromonas gingivalis LPS-induced osteoclast formation via NFATc1 activation.
    Usui M; Okamatsu Y; Sato T; Hanatani T; Moritani Y; Sano K; Yamamoto M; Nakashima K
    Arch Oral Biol; 2016 Jun; 66():77-85. PubMed ID: 26921718
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of Nrf2 in bone metabolism.
    Sun YX; Xu AH; Yang Y; Li J
    J Biomed Sci; 2015 Oct; 22():101. PubMed ID: 26511009
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Deficiency of stress-associated gene
    Shiraki M; Xu X; Iovanna JL; Kukita T; Hirata H; Kamohara A; Kubota Y; Miyamoto H; Mawatari M; Kukita A
    FASEB J; 2019 Aug; 33(8):8836-8852. PubMed ID: 31067083
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Poligoni Multiflori Radix enhances osteoblast formation and reduces osteoclast differentiation.
    Han SY; Lee KH; Kim YK
    Int J Mol Med; 2018 Jul; 42(1):331-345. PubMed ID: 29620250
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Regulation of osteoclastogenesis by osteocytes through growth differentiation factor-15].
    Hinoi E
    Yakugaku Zasshi; 2014; 134(12):1259-63. PubMed ID: 25452236
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cxcl9l and Cxcr3.2 regulate recruitment of osteoclast progenitors to bone matrix in a medaka osteoporosis model.
    Phan QT; Tan WH; Liu R; Sundaram S; Buettner A; Kneitz S; Cheong B; Vyas H; Mathavan S; Schartl M; Winkler C
    Proc Natl Acad Sci U S A; 2020 Aug; 117(32):19276-19286. PubMed ID: 32719141
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Glucocorticoid receptor signaling in bone cells.
    Moutsatsou P; Kassi E; Papavassiliou AG
    Trends Mol Med; 2012 Jun; 18(6):348-59. PubMed ID: 22578718
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.